Barbara Pistilli, MD
Gustave Roussy Cancer Center · Gustave Roussy, Villejuif, France · Gustave Roussy, Cancer Campus, Grand Paris
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Barbara Pistilli, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:10 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07294430 · Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate.UNICANCER · not yet recruiting · Locally Advanced or Metastatic Breast Cancer · principal investigator
- Ph2NCT07259226 · Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful BiomarkersUNICANCER · recruiting · Advanced Breast Cancer, Advanced Gastric Cancer, Advanced Urothelial Cancer · principal investigator
- Ph2NCT06078384 · Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBCUNICANCER · recruiting · Triple-negative Breast Cancer · principal investigator
- Ph3NCT05552001 · Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast CancerUNICANCER · active not recruiting · Triple Negative Breast Cancer, Metastatic Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.